Vaccine Trial Leader Meridian is a high-volume vaccine trial specialist with a broad therapeutic footprint and a dedicated North American investigative site network, presenting an opportunity to sell expanded vaccine research capabilities and faster study start-ups to vaccine developers seeking scale.

Strategic Network Access As the largest member of the Platinum Research Network with access to over 47 million patients globally, Meridian can offer partners enhanced patient recruitment, diverse demographics, and rapid enrollment for multi-site studies.

Acquisition & Integration Recent acquisition by Velocity Clinical Research indicates exposure to an integrated site network and potential cross-sell opportunities for sponsors seeking a larger, coordinated research footprint and streamlined trial management.

Data & Recruitment Proprietary patient databases combined with call centers and physician practice databases enable direct access to potential participants, suggesting upsell potential for sponsors needing accelerated recruitment and retention strategies.

Expansion Partnerships Recent partnerships with healthcare providers such as Hampton Family Practice highlight Meridian’s ability to expand site access in local markets, offering sponsors a path to community-based enrollment and diverse patient populations.